Suppr超能文献

慢性丙型肝炎患者血清铁蛋白与铁调素水平的相关性

Correlation Between Serum Ferritin and Hepcidin Levels in Chronic Hepatitis C Patients.

作者信息

Gill Maria, Sharafat Javaria, Ikram Faiza, Ul Qamar Misbah, Rehman Irum, Saleem Mannal, Noreen Ayesha, Khadim Nadia, Horii Arusa, Tahir Bakhtawar

机构信息

Physiology, CMH Multan Institute of Medical Sciences, Multan, PAK.

Physiology, Akhtar Saeed Medical and Dental College, Lahore, PAK.

出版信息

Cureus. 2021 Aug 27;13(8):e17484. doi: 10.7759/cureus.17484. eCollection 2021 Aug.

Abstract

Background In addition to the known role of serum ferritin as an inflammatory mediator, its role in the induction of serum hepcidin is yet to be elucidated. This study aimed to identify a correlation between serum ferritin and hepcidin levels in chronic hepatitis C (CHC) patients and healthy individuals. Methodology A total of 44 male subjects, selected by convenient sampling technique, were included in this study. The study population was divided into group I including 22 healthy males and group II including age-matched 22 CHC patients. Serum hepcidin and serum ferritin levels of study participants in both groups were assessed. Serum parameters were compared between two groups using the Mann-Whitney U test. Spearman correlation test was applied between serum ferritin and serum hepcidin in each group. P-values of ≤0.05 were considered significant. Results The median values of serum ferritin in group I and group II were in the normal range, though serum ferritin of CHC patients was significantly higher than the healthy population (p = 0.03). The median values of serum hepcidin in both groups were below the normal range. In CHC patients, a negative nonsignificant correlation (rho = -0.34, p = 0.13) was observed between serum ferritin and serum hepcidin. A positive nonsignificant correlation (rho = 0.19, p = 0.4) was observed between serum ferritin and serum hepcidin in the healthy population. Conclusions Our study could not bring forth any conclusive remarks in favor of serum ferritin as an inflammatory mediator raising serum hepcidin levels among CHC patients. A negative nonsignificant correlation between studied parameters in CHC patients may indicate the involvement of some other factor such as hepatitis C virus in the reduction of serum hepcidin levels.

摘要

背景 除了血清铁蛋白作为炎症介质的已知作用外,其在诱导血清铁调素方面的作用尚待阐明。本研究旨在确定慢性丙型肝炎(CHC)患者和健康个体中血清铁蛋白与铁调素水平之间的相关性。方法 本研究采用方便抽样技术共纳入44名男性受试者。研究人群分为I组,包括22名健康男性;II组,包括22名年龄匹配的CHC患者。评估两组研究参与者的血清铁调素和血清铁蛋白水平。使用Mann-Whitney U检验比较两组之间的血清参数。对每组中的血清铁蛋白和血清铁调素进行Spearman相关性检验。P值≤0.05被认为具有统计学意义。结果 I组和II组血清铁蛋白的中位数在正常范围内,尽管CHC患者的血清铁蛋白显著高于健康人群(p = 0.03)。两组血清铁调素的中位数均低于正常范围。在CHC患者中,血清铁蛋白与血清铁调素之间观察到负相关但无统计学意义(rho = -0.34,p = 0.13)。在健康人群中,血清铁蛋白与血清铁调素之间观察到正相关但无统计学意义(rho = 0.19,p = 0.4)。结论 我们的研究未能得出任何确凿的结论支持血清铁蛋白作为一种炎症介质提高CHC患者的血清铁调素水平。CHC患者中研究参数之间的负相关且无统计学意义可能表明其他因素如丙型肝炎病毒参与了血清铁调素水平的降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58c/8476116/4d02aa207d2d/cureus-0013-00000017484-i01.jpg

相似文献

10
Increased serum hepcidin levels in patients with porphyria cutanea tarda.血清铁调素水平在迟发性皮肤卟啉症患者中升高。
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e68-74. doi: 10.1111/j.1468-3083.2012.04511.x. Epub 2012 Mar 16.

本文引用的文献

1
Key Milestones in HCV Discovery and Therapeutics.丙型肝炎病毒发现与治疗的关键里程碑
Innovation (Camb). 2020 Nov 6;1(3):100067. doi: 10.1016/j.xinn.2020.100067. eCollection 2020 Nov 25.
4
Iron metabolism and iron disorders revisited in the hepcidin era.铁代谢与铁代谢紊乱:在铁调素时代的再认识
Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020.
6
Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.丙型肝炎病毒感染中的线粒体损伤和铁代谢失调。
Free Radic Biol Med. 2019 Mar;133:193-199. doi: 10.1016/j.freeradbiomed.2018.09.044. Epub 2018 Sep 27.
7
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.慢性肝脏疾病中的线粒体功能障碍与信号转导
Gastroenterology. 2018 Sep;155(3):629-647. doi: 10.1053/j.gastro.2018.06.083. Epub 2018 Aug 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验